Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.092 AUD | +6.98% | -1.08% | -36.55% |
Mar. 18 | ImpediMed Limited(ASX:IPD) added to S&P/ASX All Ordinaries Index | CI |
Feb. 27 | Impedimed Names Independent Non-Executive Chair | MT |
Sales 2024 * | 11.7M 7.62M | Sales 2025 * | 21.2M 13.81M | Capitalization | 186M 121M |
---|---|---|---|---|---|
Net income 2024 * | -21M -13.68M | Net income 2025 * | -14M -9.12M | EV / Sales 2024 * | 13.8 x |
Net cash position 2024 * | 24.26M 15.81M | Net cash position 2025 * | 14.4M 9.38M | EV / Sales 2025 * | 8.1 x |
P/E ratio 2024 * |
-9.94
x | P/E ratio 2025 * |
-15.9
x | Employees | 76 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 85.8% |
Latest transcript on ImpediMed Limited
1 day | +6.98% | ||
1 week | -3.16% | ||
Current month | +10.84% | ||
1 month | +15.00% | ||
3 months | -31.85% | ||
6 months | -45.88% | ||
Current year | -36.55% |
Managers | Title | Age | Since |
---|---|---|---|
Parmjot Bains
CEO | Chief Executive Officer | - | Jan. 07 |
McGregor Grant
DFI | Director of Finance/CFO | - | 23-09-27 |
Shashi Tripathi
COO | Chief Operating Officer | - | 18-07-01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Parmjot Bains
CEO | Chief Executive Officer | - | Jan. 07 |
McGregor Grant
DFI | Director of Finance/CFO | - | 23-09-27 |
Chairman | - | 23-09-27 |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 0.092 | +6.98% | 1,158,154 |
24-03-27 | 0.086 | 0.00% | 784,145 |
24-03-26 | 0.086 | -1.15% | 1,049,915 |
24-03-25 | 0.087 | -1.14% | 1,645,633 |
24-03-22 | 0.088 | -5.38% | 3,208,157 |
Delayed Quote Australian S.E., March 28, 2024 at 01:10 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-36.55% | 114M | |
+9.50% | 221B | |
+7.95% | 184B | |
+18.30% | 142B | |
+18.47% | 101B | |
+7.83% | 68.07B | |
+25.32% | 57.27B | |
-3.69% | 47.42B | |
+4.66% | 43.19B | |
+15.12% | 28.84B |